Specification: 10MG Molecular Formula: C62H98N16O22 Molecular Weight: 1419.53 g/mol Sequence: Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val This product is intended for laboratory and research purposes only
Specific Patient Groups: Type 2 Diabetes and Weight Loss Sublingual semaglutide is designed to help two main groups of people: those with type 2 diabetes and individuals seeking to lose weight
The peptide market is, frankly, a minefield of low-quality, impure products
FDA approval of exenatide, its first generic injectable GLP-1 agonist, Amneal (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva Pharmaceuticals (2025) Exenatide, DailyMed (2025) Byetta, DailyMed (2025) Liraglutide (generic Victoza), DailyMed (2025) Liraglutide (generic Saxenda), DailyMed (2025) Victoza, DailyMed (2025) Saxenda, DailyMed (2025) Compounding and the FDA: Questions and answers, U.S
What to eat while taking a GLP-1 Because you will most likely be eating less when taking a GLP-1, you want to prioritize foods that are nutrient-dense and help you feel your best